<DOC>
	<DOC>NCT00488865</DOC>
	<brief_summary>This study is designed to evaluate the safety and efficacy of the RexMedical Option* Vena Cava Filter in the treatment of patients who are at increased risk for Pulmonary Embolism and require caval interruption.</brief_summary>
	<brief_title>RexMedical- Option* Vena Cava Filter IDE Study</brief_title>
	<detailed_description />
	<mesh_term>Embolism</mesh_term>
	<mesh_term>Pulmonary Embolism</mesh_term>
	<criteria>Key Patient is at least 18 years of age Patient requires temporary or permanent caval interruption Key Patient has preexisting filter implanted in her/her vasculature or has undergone filter retrieval within 60 days prior to study device implant Patient is currently enrolled in another investigational device or drug trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2010</verification_date>
	<keyword>increased risk for PE require caval interruption</keyword>
</DOC>